Drugs Induced Stevens-Johnson Syndrome

dc.contributor.authorÖnder, Elif
dc.contributor.authorAlbayrak, Hülya
dc.contributor.authorGürlevik, Zehra
dc.contributor.authorAydın, Yusuf
dc.date.accessioned2020-04-30T13:32:20Z
dc.date.available2020-04-30T13:32:20Z
dc.date.issued2010
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractStevens Johnson Syndrome (SJS) is a life threatening mucocutaneous skin disease that mostly developed after using some drug. SJS mostly appear between 2-4th decades. Mucocutaneous lesions were seen between 1-14 days of drug intake. And these lesions spread diffusely all around the body. First treatment choice is the stopping of drug that cause SJS and giving supporting treatment. After understanding of underlying cytotoxic and immunological mechanism of SJS, new treatment approaches were developed and mortality of disease was reduced. We herein report a short review of drug induced SJS and its treatment. © 2010 Düzce Medical Journal.en_US
dc.identifier.endpage103en_US
dc.identifier.issn1307671X
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage98en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/243
dc.identifier.volume12en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDrugs; Stevens Johnson syndromeen_US
dc.titleDrugs Induced Stevens-Johnson Syndromeen_US
dc.title.alternativeİlaçlara bağli Stevens-Johnson sendromuen_US
dc.typeReview Articleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0243.pdf
Size:
538.44 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text